incid
lower
airway
infect
immunocompromis
patient
high
cours
diseas
usual
sever
immunocompet
host
sousa
et
al
bonatti
et
al
mortal
rate
larg
depend
type
sever
immunosuppress
highest
rate
report
hematopoiet
stem
cell
transplant
hsct
somewhat
lower
solid
organ
transplant
sot
recipi
patient
hematolog
malign
hm
cervera
et
al
et
al
also
shown
outcom
pulmonari
infect
significantli
affect
delay
diagnosi
specif
etiolog
increas
mortal
rate
report
patient
etiolog
infect
ascertain
within
first
day
onset
symptom
compar
later
diagnosi
et
al
etiolog
lower
respiratori
tract
infect
immunocompromis
patient
divers
includ
common
bacteria
uncommon
bacteri
agent
opportunist
pathogen
variou
fungal
speci
virus
although
atyp
bacteria
import
caus
pulmonari
infect
gener
popul
data
role
pathogen
immunocompromis
patient
rel
scarc
immunocompet
host
mycoplasma
pneumonia
chlamydophila
pneumonia
respons
commun
acquir
pneumonia
cap
case
respect
singanayagam
et
al
et
al
gleason
major
infect
affect
children
young
adult
present
mild
selflimit
diseas
capelastegui
et
al
howev
even
patient
may
requir
hospit
admiss
inhospit
death
rate
may
high
preval
legionella
pneumophila
pneumonia
gener
popul
slightli
lower
infect
usual
sever
two
studi
l
pneumophila
respons
cap
requir
hospit
yu
stout
gleason
hand
recent
data
confirm
relat
l
pneumophila
infect
increas
inhospit
mortal
rate
capelastegui
et
al
might
hypothes
cours
atyp
pulmonari
infect
immunocompromis
patient
sever
gener
popul
coinfect
atyp
pathogen
aggrav
cours
pulmonari
diseas
caus
typic
bacteria
fungi
surprisingli
littl
data
incid
clinic
featur
atyp
pulmonari
infect
immunocompromis
patient
accord
avail
public
incid
infect
quit
low
corti
et
al
jain
et
al
perez
leigh
howev
case
life
threaten
pneumonia
caus
c
pneumonia
l
pneumophila
describ
di
stefano
et
al
heinemann
et
al
whether
true
preval
atyp
pathogen
infect
immunocompromis
host
low
underestim
due
low
sensit
diagnost
method
seem
interest
issu
must
realiz
cultur
atyp
bacteria
difficult
demand
offer
laboratori
serolog
method
includ
specif
igm
igg
antibodi
detect
serum
limit
clinic
applic
due
delay
diagnosi
suboptim
sensit
patient
immunoglobulin
defici
fals
neg
result
bartlett
hammerschlag
welti
et
al
likewis
l
pneumophila
antigen
detect
urin
limit
sensit
neg
result
test
exclud
infect
serotyp
l
pneumophila
strain
introduct
polymeras
chain
reaction
pcr
base
method
identifi
specif
genet
materi
differ
biolog
sampl
includ
broncholaveolar
lavag
fluid
balf
throat
swab
nasopharyng
sampl
enabl
rapid
sensit
specif
diagnosi
atyp
pathogen
infect
even
patient
alreadi
treat
antibiot
murdoch
welti
et
al
murdoch
therefor
aim
studi
evalu
preval
atyp
lower
airway
infect
use
nest
pcr
npcr
method
patient
variou
type
immunosuppress
analyz
clinic
characterist
infect
studi
protocol
approv
institut
bioethic
committe
studi
group
consist
nonhiv
immunocompromis
patient
differ
underli
diseas
clinic
radiolog
sign
pulmonari
infect
due
incomplet
data
eight
patient
patient
elig
final
analysi
median
age
rang
year
fm
patient
treat
larg
multidisciplinari
univers
hospit
special
center
hematolog
hematolog
oncolog
warsaw
poland
met
follow
inclus
criteria
known
immunosuppress
clinic
radiolog
sign
symptom
pulmonari
infect
sign
inform
consent
diagnost
bronchoscopi
immunosuppress
defin
hematolog
diseas
malign
hdm
immunosuppress
chemotherapi
due
malign
diseas
immunosuppress
treatment
due
solid
organ
hematolog
stem
cell
transplant
sotr
immunosuppress
therapi
due
autoimmun
diseas
miscellan
chronic
diseas
could
affect
immun
state
misc
group
clinic
sign
symptom
suggest
lower
airway
infect
includ
recent
cough
fever
dyspnea
auscultatori
find
radiolog
find
consist
pulmonari
infect
defin
presenc
follow
pulmonari
abnorm
singl
multifoc
consolid
area
ground
glass
opac
pulmonari
nodul
interstiti
pattern
could
explain
caus
eg
progress
lung
tumor
new
lung
metastas
exclus
criteria
follow
known
aid
posit
result
hiv
test
contraind
diagnost
bronchoscopi
ie
unstabl
hemodynam
statu
ga
exchang
abnorm
result
hypoxemia
despit
low
flow
oxygen
therapi
respiratori
failur
requir
mechan
ventil
patient
underw
fiberopt
bronchoscopi
local
anesthesia
insert
bronchoscop
olympu
bf
pentax
eb
k
tokyo
japan
preced
premed
atropin
sulphat
mg
sc
midazolam
mg
po
local
anesthesia
upper
airway
lidocain
suction
avoid
upper
airway
trachea
minim
contamin
work
channel
bronchoscop
addit
portion
lidocain
appli
lower
airway
necessari
visual
inspect
lower
airway
bronchoscop
wedg
segment
subsegment
bronchu
accord
local
radiolog
abnorm
case
relev
radiolog
abnorm
bronchoscop
wedg
medial
later
segment
right
middl
lobe
two
hundr
millilit
steril
prewarm
salin
solut
instil
either
ten
ml
portion
four
ml
portion
withdrawn
gentl
suction
bronchoalveolar
lavag
fluid
balf
collect
steril
polypropylen
tube
sampl
balf
sent
microbiolog
examin
includ
direct
microscopi
cultur
fungal
antigen
detect
appropri
one
millilit
sampl
balf
frozen
total
dna
extract
balf
use
isol
kit
commerci
qualit
amplif
assay
pneumotri
oligomix
alert
base
nest
pcr
method
use
detect
specif
dna
sequenc
l
pneumophila
c
pneumonia
pneumonia
defrozen
balf
sampl
also
betaglobin
oligomix
alert
use
human
gene
standard
use
extern
control
dna
extract
amplif
reagent
describ
suppli
nanogen
advanc
diagnost
srl
turin
itali
investig
perform
accord
manufactur
instruct
presum
limit
detect
lod
pcr
assay
use
establish
dozen
copiesml
data
clinic
radiolog
sign
symptom
result
microbiolog
examin
balf
retrospect
collect
load
electron
databas
addit
result
microbiolog
studi
includ
blood
sampl
throat
swab
sputum
urin
stool
also
analyz
consist
aim
studi
result
assess
patient
differ
type
immunosuppress
quantit
variabl
present
median
interquartil
rang
iqr
andor
rang
qualit
variabl
present
number
percentag
nonparametr
mannwhitney
u
test
chisquar
test
use
assess
differ
variabl
differ
group
pvalu
consid
statist
signific
statist
analysi
perform
use
statist
softwar
packag
statistica
ver
statsoft
inc
tulsa
ok
demograph
data
underli
diseas
present
tabl
patient
unevenli
distribut
hdm
group
misc
group
patient
sort
group
common
underli
diseas
acut
myeloid
leukemia
aml
respons
almost
one
third
caus
immunosuppress
aml
follow
chronic
lymphocyt
leukemia
n
caus
nonhodgkin
lymphoma
n
caus
clinic
sign
symptom
well
radiograph
data
demonstr
tabl
major
clinic
symptom
fever
found
patient
cough
report
patient
typic
sign
symptom
lower
airway
infect
patient
pulmonari
diseas
patient
diagnos
base
new
radiolog
find
chest
radiograph
thorax
ct
scan
avail
patient
respect
common
radiograph
manifest
lung
consolid
found
patient
predomin
bilater
radiograph
lung
involv
demonstr
half
patient
ie
patient
base
chest
radiograph
thorax
ct
scan
respect
isol
right
lung
involv
found
chest
radiograph
thorax
ct
scan
tabl
present
clinic
radiolog
microbiolog
characterist
patient
dna
atyp
pathogen
identifi
balf
none
sampl
specif
l
pneumophila
dna
sequenc
found
pneumonia
specif
dna
identifi
sampl
collect
patient
two
sampl
test
posit
c
pneumonia
dna
patient
identifi
atyp
pathogen
fever
commonli
report
symptom
patient
bilater
lung
involv
demonstr
patient
coinfect
differ
microorgan
detect
base
balf
blood
microbiolog
studi
despit
broad
spectrum
antibiot
antifung
therapi
patient
die
patient
posit
result
blood
cultur
baumanii
p
aeruginosa
found
two
one
patient
respect
present
studi
demonstr
low
preval
atyp
pulmonari
infect
nonhiv
immunocompromis
patient
pneumonia
c
pneumonia
l
pneumophila
found
patient
respect
thu
preval
infect
studi
somewhat
lower
usual
report
immunocompet
patient
cap
capelastegui
et
al
et
al
hand
percentag
patient
atyp
pathogen
except
l
pneumophila
identifi
slightli
higher
compar
studi
immunocompromis
host
cervera
et
al
hohenth
et
al
jain
et
al
et
al
differ
easili
explain
multipl
factor
influenc
result
variou
studi
includ
environment
factor
commun
hospit
acquir
infect
season
local
epidemiolog
situat
type
sever
durat
immunosuppress
method
appli
pathogen
detect
identif
report
method
per
entir
studi
group
per
subgroup
specif
caus
immunoincompet
treatment
appli
prior
microbiolog
sampl
despit
condit
author
agre
atyp
pulmonari
infect
immunocompromis
host
rather
uncommon
depend
sourc
data
typic
bacteria
fungi
virus
respons
pulmonari
infect
nonhiv
immunocompromis
patient
respect
camp
serra
et
al
jain
et
al
et
al
et
al
addit
polymicrobi
infect
caus
pathogen
outlin
diagnos
patient
atyp
pathogen
found
singl
case
studi
diagnosi
pulmonari
infect
caus
atyp
bacteria
base
sole
microbiolog
test
ie
identif
specif
dna
sequenc
lavag
fluid
collect
directli
site
infect
role
fiberopt
bronchoscopi
bronchoalveolar
lavag
diagnost
tool
immunocompromis
patient
pulmonari
infiltr
well
establish
shown
earli
bronchoscopi
day
significantli
higher
diagnost
yield
pulmonari
infect
late
bronchoscopi
vs
p
lucena
et
al
role
diagnost
method
cultur
workup
immunocompromis
patient
pulmonari
infect
also
posit
verifi
albeit
elisa
test
detect
c
pneumonia
andor
pneumonia
antibodi
limit
due
wellknown
cross
reaction
chlamydia
mycoplasma
speci
hohenth
et
al
shown
use
pcr
antigen
detect
identifi
infecti
agent
balf
patient
hematolog
malign
significantli
improv
diagnost
yield
unfortun
although
pneumonia
c
pneumonia
pcr
test
perform
balf
sampl
respect
author
neither
present
discuss
result
similar
present
studi
none
balf
sampl
evalu
hohenth
et
al
test
posit
legionella
spp
pcr
test
howev
two
point
mention
compar
result
two
studi
firstli
number
balf
sampl
evalu
hohenth
et
al
almost
twofold
higher
present
studi
secondli
finnish
studi
pcr
method
cultur
appli
one
patient
posit
cultur
neg
legionella
spp
pcr
test
thu
exclud
patient
legionellosi
could
found
present
studi
pcr
diagnost
method
use
nevertheless
result
studi
point
low
preval
l
pneumophila
pulmonari
infect
immunocompromis
patient
seem
inconsist
result
earlier
studi
show
hematolog
malign
signific
risk
factor
rate
ratio
l
pneumophila
pneumonia
marston
et
al
furthermor
cours
pulmonari
infect
immunocompromis
patient
often
sever
l
pneumophila
wellknown
pathogen
respons
sever
pneumonia
higher
preval
infect
could
expect
immunocompromis
patient
therefor
methodolog
issu
could
neg
influenc
preval
l
pneumophila
infect
found
present
studi
consid
hypothesi
extrem
low
preval
l
pneumophila
infect
relat
fals
neg
pcr
result
highli
unlik
contrari
mention
data
posit
l
pneumophila
cultur
fals
neg
pcr
test
numer
studi
demonstr
legionella
pcr
sensit
equal
greater
cultur
pcr
test
give
fals
neg
result
polymeras
inhibitor
present
biolog
sampl
hammerschlag
shown
pneumonia
infect
throat
swab
prefer
nasopharyng
sampl
due
lower
rate
pcr
inhibitor
murdoch
pcr
inhibitor
usual
nonspecif
presenc
would
caus
fals
neg
result
term
l
pneumophila
infect
also
pathogen
ie
pneumonia
c
pneumonia
case
studi
extern
control
dna
extract
amplif
use
simultan
inhibit
observ
studi
earli
adequ
antibiot
therapi
sampl
collect
anoth
caus
fals
neg
result
microbiolog
studi
fact
signific
proport
patient
includ
patient
atyp
bacteri
infect
treat
macrolid
fluoroquinolon
time
diagnost
bronchoscopi
prior
studi
patient
pneumonia
shown
bronchoalveolar
lavag
perform
within
day
antibiot
therapi
onset
diagnost
yield
diagnost
valu
decreas
lavag
done
later
day
treatment
initi
respect
kottmann
et
al
argument
confound
role
prior
treatment
result
obtain
present
studi
pcr
test
allow
detect
genet
materi
caus
pathogen
even
week
initi
antibiot
therapi
welti
et
al
interestingli
atyp
pathogen
identifi
present
studi
exclus
male
may
partial
explain
higher
proport
male
nevertheless
believ
suffici
explan
find
genderrel
differ
incid
atyp
bacteri
infect
also
report
previou
studi
et
al
found
incid
cap
caus
c
pneumonia
l
pneumophila
gener
popul
twofold
tenfold
higher
male
femal
respect
agerel
differ
preval
atyp
pathogen
infect
also
mention
present
studi
median
age
patient
pneumonia
infect
year
somewhat
inconsist
et
al
find
report
highest
incid
mpneumonia
cap
young
elderli
peopl
lowest
year
age
knowledg
specif
data
publish
genderrel
agerel
differ
preval
atyp
pathogen
infect
immunocompromis
patient
therefor
could
confront
observ
realiz
number
patient
atyp
pathogen
infect
small
draw
unequivoc
conclus
relationship
age
gender
preval
pneumonia
c
pneumonia
infect
mortal
rate
nine
patient
pneumonia
c
pneumonia
infect
rel
high
believ
neither
cours
diseas
mortal
rate
relat
exclus
atyp
bacteri
infect
context
underlin
eight
patient
coinfect
microorgan
found
posit
balf
andor
blood
cultur
system
bacteri
coinfect
prove
three
patient
die
baumanii
p
aeruginosa
cultur
blood
sampl
find
consist
result
three
earlier
studi
report
coinfect
least
one
anoth
pathogen
patient
pneumonia
c
pneumonia
l
pneumophila
infect
respect
welti
et
al
gleason
hammerschlag
perhap
destruct
airway
epitheli
layer
ciliostat
effect
pathogen
facilit
bacteri
infect
awar
sever
limit
studi
due
small
sampl
size
confid
interv
could
calcul
proport
pneumonia
c
pneumonia
infect
respect
valu
may
question
confid
low
preval
atyp
pathogen
infect
studi
group
mark
disproport
number
patient
differ
caus
immunosuppress
fact
studi
group
includ
mainli
patient
hematolog
malign
henc
result
refer
mostli
group
immunocompromis
patient
also
could
analyz
relationship
underli
diseas
preval
clinic
cours
atyp
infect
signific
limit
studi
associ
use
pcr
identifi
atyp
bacteria
infect
consequ
unabl
assess
discuss
potenti
fals
posit
fals
neg
result
previou
studi
includ
pignanelli
et
al
shown
concomit
use
two
differ
test
provid
higher
diagnost
accuraci
thu
question
true
etiolog
lower
respiratori
tract
infect
patient
still
pend
case
find
put
etiolog
agent
could
common
respiratori
virus
metapneumoviru
coronaviru
bocaviru
routin
detect
therefor
use
widerang
diagnost
tool
eg
respiratori
panel
base
multiplex
nest
pcr
assay
could
help
improv
outcom
immunocompromis
patient
dzieciatkowski
et
al
conclus
found
atyp
lower
airway
infect
uncommon
immunocompromis
patient
particularli
refer
l
pneumophila
pneumonia
major
atyp
pulmonari
infect
coinfect
rather
singl
pathogen
infect
